Reports of Radiotherapy and Oncology

Published by: Kowsar

Olfactory Neuroblastoma: A 15-Year Single Institution Experience

Bijan Khademi 1 , Sima Safari 2 , Sare Hosseini 3 , * and Mohammad Mohammadianpanah 4
Authors Information
1 Department of Otolaryngology, Khalili Hospital, Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Student Research Committee, Department of Otolaryngology, and Head and Neck Surgery, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Radiation Oncology, Cancer Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Reports of Radiotherapy and Oncology: September 30, 2015, 2 (3); e4472
  • Published Online: September 27, 2015
  • Article Type: Research Article
  • Received: July 11, 2015
  • Revised: August 22, 2015
  • Accepted: September 12, 2015
  • DOI: 10.17795/rro-4472

To Cite: Khademi B, Safari S, Hosseini S, Mohammadianpanah M. Olfactory Neuroblastoma: A 15-Year Single Institution Experience, Rep Radiother Oncol. 2015 ; 2(3):e4472. doi: 10.17795/rro-4472.

Copyright © 2015, Iranian Society of Clinical Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Khademi B, Moradi A, Hoseini S, Mohammadianpanah M. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg. 2009; 13(4): 191-9[DOI][PubMed]
  • 2. Khademi B, Bahranifard H, Nasrollahi H, Mohammadianpanah M. [Primary mucosal melanoma of the sinonasal tract: report of 18 patients and analysis of 1077 patients in the literature]. Braz J Otorhinolaryngol. 2011; 77(1): 58-64[PubMed]
  • 3. Khademi B, Owji SM, Khosh KJ, Mohammadianpanah M, Gandomi B. Description of a neural sheath tumor of the trigeminal nerve: immunohistochemical and electron microscopy study. Sao Paulo Med J. 2006; 124(6): 333-5[PubMed]
  • 4. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001; 2(11): 683-90
  • 5. Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007; 133(3): 276-80[DOI][PubMed]
  • 6. Bak M, Wein RO. Esthesioneuroblastoma: a contemporary review of diagnosis and management. Hematol Oncol Clin North Am. 2012; 26(6): 1185-207[DOI][PubMed]
  • 7. Thompson LD. Olfactory neuroblastoma. Head Neck Pathol. 2009; 3(3): 252-9[DOI][PubMed]
  • 8. Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol. 2009; 16(5): 322-31[DOI][PubMed]
  • 9. Tajudeen BA, Arshi A, Suh JD, Palma-Diaz MF, Bergsneider M, Abemayor E, et al. Esthesioneuroblastoma: an update on the UCLA experience, 2002-2013. J Neurol Surg B Skull Base. 2015; 76(1): 43-9[DOI][PubMed]
  • 10. Oskouian RJJ, Jane JAS, Dumont AS, Sheehan JM, Laurent JJ, Levine PA. Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience. Neurosurg Focus. 2002; 12(5)[PubMed]
  • 11. Theilgaard SA, Buchwald C, Ingeholm P, Kornum Larsen S, Eriksen JG, Sand Hansen H. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol. 2003; 123(3): 433-9[PubMed]
  • 12. Tsang RK, Tsang AC, Lam JW, Ho WK, Leung GK. Long-term results of endoscopic-assisted cranionasal resection for olfactory neuroblastoma - single centre experience of fourteen patients. Clin Otolaryngol. 2015; 40(3): 274-7[DOI][PubMed]
  • 13. Proust F. Treatment of esthesioneuroblastoma: a double approach? Neurochirurgie. 2015; 61(1): 54[DOI][PubMed]
  • 14. Jarzabski A, Kiprian D, Szutkowski Z, Kawecki A, Michalski W. [The results of combined treatment patients with olfactory neuroblastoma in material of Cancer Center in Warsaw]. Otolaryngol Pol. 2011; 65(5 Suppl): 93-7[DOI][PubMed]
  • 15. Modesto A, Blanchard P, Tao YG, Rives M, Janot F, Serrano E, et al. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma. Oral Oncol. 2013; 49(8): 830-4[DOI][PubMed]
  • 16. Diaz EMJ, Johnigan RH, Pero C, El-Naggar AK, Roberts DB, Barker JL, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005; 27(2): 138-49[DOI][PubMed]
  • 17. Platek ME, Merzianu M, Mashtare TL, Popat SR, Rigual NR, Warren GW, et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011; 6: 41[DOI][PubMed]
  • 18. Chao KS, Kaplan C, Simpson JR, Haughey B, Spector GJ, Sessions DG, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck. 2001; 23(9): 749-57[PubMed]
  • 19. Petruzzelli GJ, Howell JB, Pederson A, Origitano TC, Byrne RW, Munoz L, et al. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence. Am J Otolaryngol. 2015; 36(4): 547-53[DOI][PubMed]
  • 20. McLean JN, Nunley SR, Klass C, Moore C, Muller S, Johnstone PA. Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg. 2007; 136(6): 998-1002[DOI][PubMed]
  • 21. McElroy EAJ, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery. 1998; 42(5): 1023-7[PubMed]
  • 22. Porter AB, Bernold DM, Giannini C, Foote RL, Link MJ, Olsen KD, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol. 2008; 90(2): 201-4[DOI][PubMed]
  • 23. Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck. 2000; 22(6): 550-8[PubMed]
  • 24. Kim HJ, Cho HJ, Kim KS, Lee HS, Kim HJ, Jung E, et al. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma. J Craniomaxillofac Surg. 2008; 36(1): 47-52[DOI][PubMed]
  • 25. Song CM, Won TB, Lee CH, Kim DY, Rhee CS. Treatment modalities and outcomes of olfactory neuroblastoma. Laryngoscope. 2012; 122(11): 2389-95[DOI][PubMed]
  • 26. Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB. Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg. 2014; 140(12): 1124-9[DOI][PubMed]
  • 27. Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015; 9(1): 51-9[DOI][PubMed]
  • 28. Nishimura H, Ogino T, Kawashima M, Nihei K, Arahira S, Onozawa M, et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys. 2007; 68(3): 758-62[DOI][PubMed]
  • 29. Rimmer J, Lund VJ, Beale T, Wei WI, Howard D. Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol. Laryngoscope. 2014; 124(7): 1542-9[DOI][PubMed]
  • 30. De Bonnecaze G, Chaput B, Al Hawat A, Filleron T, Vairel B, Serrano E, et al. Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma. Acta Otolaryngol. 2014; 134(12): 1259-64[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments